Typicality: | 0.347 |
Saliency: | 0.432 |
over existing therapies | 57 | other |
on a clinically significant endpoint | 16 | other |
in effectiveness | 7 | other |
drug → demonstrate → substantial improvement | 58 |
drug → demonstrate → substantial improvements | 5 |
drug → demonstrate → significant improvements | 4 |
drug → show → significant improvement | 4 |
drug → demonstrate → significant improvement | 3 |
drug → show → substantial improvement | 3 |
negative | neutral | positive |
0.007 | 0.211 | 0.782 |
Raw frequency | 77 |
Normalized frequency | 0.432 |
Modifier score | 0.500 |
Perplexity | 461.108 |